Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Cell Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06393738
What this trial is testing

ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

Who this might be right for
Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL)Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)
Arvinas Inc. 329
Testing effectiveness (Phase 2)Looking for participantsNCT05031897
What this trial is testing

Two Step Haplo With Radiation Conditioning

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAdult T-Cell Leukemia/Lymphoma+14 more
Thomas Jefferson University 63
Testing effectiveness (Phase 2)Looking for participantsNCT05260957
What this trial is testing

CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).

Who this might be right for
Refractory Non-Hodgkin LymphomaRelapsed Non Hodgkin LymphomaAggressive Non-Hodgkin Lymphoma
Lazaros Lekakis 22
Testing effectiveness (Phase 2)Looking for participantsNCT05338931
What this trial is testing

Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Who this might be right for
B-cell Non Hodgkin Lymphoma
AbClon 82
Early research (Phase 1)Looking for participantsNCT07052305
What this trial is testing

NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma

Who this might be right for
Large B-cell Lymphoma
Washington University School of Medicine 24
Not applicableUnknownNCT04511351
What this trial is testing

Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell Lymphoma

Who this might be right for
Lymphoma
Chinese Academy of Medical Sciences 76
Early research (Phase 1)Study completedNCT00005639
What this trial is testing

Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 34
Early research (Phase 1)Active Not RecruitingNCT02732275
What this trial is testing

DS-3201b in Participants With Lymphomas

Who this might be right for
Lymphoma, MalignantNon-hodgkin Lymphoma
Daiichi Sankyo Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT00117988
What this trial is testing

17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaRecurrent Adult Hodgkin LymphomaRecurrent Mantle Cell Lymphoma
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Study completedNCT01226472
What this trial is testing

Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001

Who this might be right for
Peripheral T-cell LymphomaCutaneous T-cell Lymphoma
Kyowa Kirin Co., Ltd. 1
Not applicableWithdrawnNCT01801670
What this trial is testing

Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study

Who this might be right for
Pruritus
Boston University
Early research (Phase 1)Study completedNCT02576496
What this trial is testing

Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

Who this might be right for
Hematological MalignanciesMultiple MyelomaHodgkin's Lymphoma+1 more
Mundipharma Research Limited 106
Testing effectiveness (Phase 2)Study completedNCT00007345
What this trial is testing

Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma

Who this might be right for
Cutaneous T Cell LymphomaPeripheral T Cell Lymphoma
National Cancer Institute (NCI) 131
Early research (Phase 1)Study completedNCT02057445
What this trial is testing

3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma

Who this might be right for
Non-Hodgkins LymphomaHodgkins LymphomaLymphoproliferative Disorder
New York Medical College 1
Testing effectiveness (Phase 2)Study completedNCT02424045
What this trial is testing

Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma

Who this might be right for
T-cell Lymphoma
Samsung Medical Center 30
Large-scale testing (Phase 3)Study completedNCT00265837
What this trial is testing

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72
Not applicableUnknownNCT05821192
What this trial is testing

Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.

Who this might be right for
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell Lymphoma
Ou Bai, MD/PHD 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT01746849
What this trial is testing

Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
LeukemiaMultiple MyelomaMyelodysplastic Syndrome+1 more
Memorial Sloan Kettering Cancer Center 82
Not applicableEnded earlyNCT00952185
What this trial is testing

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more
City of Hope Medical Center 9
Early research (Phase 1)Ended earlyNCT02061449
What this trial is testing

Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma

Who this might be right for
Cutaneous T-cell Lymphoma
NYU Langone Health 3
Next Page